ArticleRespiratory research2026
Multi-omics characterises early immune divergence associated with infection-related deterioration after lung transplantation.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundEarly adverse outcomes after lung transplantation often manifest as infection-associated clinical deterioration. Such events are closely intertwined with dysregulated perioperative immune reconstitution and are influenced by immunosuppressive therapy. A systematic characterisation of the perioperative immune landscape and potentially actionable pathways may facilitate understanding of early trajectory divergence and inform perioperative monitoring and management.
methodsWe conducted longitudinal sampling and immune profiling at predefined perioperative time points in lung transplant recipients. A deeply profiled discovery cohort was constructed using multi-omics approaches including single-cell transcriptomics, B-cell receptor sequencing, plasma proteomics, and flow cytometry, and key findings were externally validated in an independent validation cohort. Healthy donors provided reference baselines for peripheral immune states.
resultsOutcome-associated immune divergence was detectable early and became more apparent by post-operative Day 7 (T2). At baseline (T0), recipients who later died tended to show a higher burden of CD177⁺ neutrophils, which may reflect a subclinical inflammatory state and a propensity for NETs-related activity. By T2, the Death group more frequently exhibited persistent inflammatory and infection-related deterioration with features of maladaptive humoral reconstitution, including plasmablast/plasma cell expansion, naïve B-cell depletion, skewed BCR clonality with restricted somatic hypermutation, and heightened BAFF/NETs activity alongside IgA-biased responses. The Live group generally showed a more resolving inflammatory course with relative preservation of B-cell homeostasis.
conclusionsThese data suggest that CD177⁺ neutrophil–linked NETs–BAFF activity may contribute to early adverse trajectories after lung transplantation and may be informative for perioperative risk stratification. A composite assessment at T0 and T2 integrating CD177⁺ neutrophils, BAFF/NETs readouts, B-cell dynamics and immunoglobulin profiles may help identify recipients at risk of infection-related deterioration and nominate the first post-operative week as a potential window for carefully timed immune modulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.